GlucoTrack Inc (GCTK) Down -99.76% From Its 52-Week High, But Growth Potential Is Changing Over Time

GlucoTrack Inc (NASDAQ:GCTK) currently has a daily average trading volume of 6.23M but it saw 2084398 shares traded in last market. With a market cap of 2.52M USD, the company’s current market price of $0.24 came falling about -4.57 while comparing to the previous closing price of $0.25. In past 52 weeks, the stock remained buoying in the range of price level as high as $99.00 and as low as $0.22. In the recent trading on the day, stock has struck highest price mark of $0.2419 while lowest mark touched by it was $0.2729.

Taking a look at 20-day trading activity of GlucoTrack Inc (GCTK) gives us an average price of $0.3412, while its current price level is -99.76% below from 52-week high level whereas it is 9.09% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.7989 while that of 200 days or SMA-200 reads an average of $23.5854. A closer look into the stock’s movement over the week reveals that its volatility is standing at 44.20% during that period while stretching the period over a month that decreases to 22.19%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 27.62 which implies that the stock is in oversold territory.

Over the week, GCTK’s stock price is moving -37.73% down while it is -27.92% when we observe its performance for the past one month. Year-to-date it is -96.75% down and over the past year, the stock is showing a downside performance of -99.26%.

The company is expected to be releasing its next quarterly report in April, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.

Currently, GlucoTrack Inc’s total number of outstanding shares is 10.41M with 2.34% of that held by the insiders while 0.44% of its common stock has been owned by the institutions. Company’s return on equity (ROE) at -1943.32%. Stock’s beta reads -0.14. Its return on asset (ROA) is -371.90% on average.